These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3272138)

  • 1. Comparison of the in vitro cytotoxicity of cyclodisone with a series of structurally related analogues.
    Gibson NW
    Anticancer Drug Des; 1988 Dec; 3(3):199-204. PubMed ID: 3272138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA damage and cytotoxicity induced in two human colon carcinoma cell lines by cyclodisone.
    Gibson NW
    Cancer Res; 1989 Jan; 49(1):154-7. PubMed ID: 2908842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity analysis of the formation of DNA damage induced in human tumor cells by the cyclodisone class of anti-tumor agent.
    Berardini MD; Pacheco DY; Gibson NW
    Anticancer Drug Des; 1991 May; 6(2):119-27. PubMed ID: 2039582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
    Henderson ND; Plumb JA; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA reactivity and in vitro cytotoxicity of the novel antitumor agent 1,5,2,4-dioxadithiepane-2,2,4,4-tetraoxide (NSC-348948) in human embryo cells.
    Gibson NW; Hartley JA; Kohn KW
    Cancer Res; 1986 Apr; 46(4 Pt 1):1679-83. PubMed ID: 3509975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. I. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl ureas.
    Dulude H; Salvador R; Gallant G
    Anticancer Res; 1995; 15(3):847-52. PubMed ID: 7645969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
    Marshall MV; Marshall MH; Degen DR; Roodman GD; Kuhn JG; Ross ME; Von Hoff DD
    Stem Cells; 1993 Jan; 11(1):62-9. PubMed ID: 8457783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid aza-steroid alkylators in the treatment of colon cancer.
    Trafalis DT
    Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
    Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
    Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
    Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
    Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.
    Rose WC; Schurig JE; Meeker JB
    Anticancer Res; 1988; 8(3):355-67. PubMed ID: 3389740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29.
    Styers TJ; Kekec A; Rodriguez R; Brown JD; Cajica J; Pan PS; Parry E; Carroll CL; Medina I; Corral R; Lapera S; Otrubova K; Pan CM; McGuire KL; McAlpine SR
    Bioorg Med Chem; 2006 Aug; 14(16):5625-31. PubMed ID: 16697205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
    Lam HY; Ng PK; Goldenberg GJ; Wong CM
    Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
    Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.